[US-AI반도체] 10/26 Wall St. Recap

NVDABULL
As a senior equity analyst, the recent news flow surrounding NVIDIA (NVDA) highlights a resilient upward trend supported by (attractive valuation) despite trading near 52-week highs, alongside medium-term price targets averaging around $326. While competitive threats such as DeepSeek and Huawei’s software initiatives aiming to reduce (dependency on NVIDIA) exist, the company’s robust ecosystem and ongoing market dominance continue to justify a strong (buy and hold) strategy.
AMDSTAY
As a senior equity analyst, I evaluate the recent news surrounding AMD. The unveiling of the (6th-generation EPYC ‘Venano’) processor and the strategic acquisition of (MangoBoost) highlight AMD’s strong push to capture the (AI inference market) and (rack-scale AI factory) infrastructure. However, the intensifying competition from NVIDIA, particularly in the CPU sector where NVIDIA is projected to lead in sales next year, presents a notable (competitive headwind) for AMD’s data center dominance. Overall, while technological advancements provide solid long-term growth catalysts, competitive pressures require close monitoring.
AVGOBEAR
As a senior equity analyst, I evaluate the recent pullback in Broadcom (AVGO), which declined by 3.05%, against the backdrop of broader market sentiment and CEO commentary. While the company maintains strong long-term fundamentals and structural growth drivers in (AI infrastructure), recent remarks from management cautioning against speculative retail behavior—likening uninformed investors to gamblers—along with short-term (market volatility), have triggered a healthy correction. Nevertheless, valuation debates persist, balancing massive historical gains against future (earnings potential).
ARMBEAR
As a senior equity analyst, the recent legal developments surrounding Arm present a nuanced yet (negative sentiment) for investor confidence. While the financial damages from the (Qualcomm lawsuit) are negligible at just $2, the jury’s verdict finding Arm in (contract breach) creates legal uncertainty and potential friction within its core (licensing business model). Despite positive long-term catalysts such as ecosystem expansion via (Boss Semiconductor) and strategic positioning in (Agentic AI infrastructure), the immediate (stock price decline) reflects heightened near-term regulatory and legal risks that warrant cautious monitoring.
ASMLSTAY
As a senior equity analyst, I evaluate ASML’s recent developments through a dual lens of robust financial resilience and strategic diversification. On one hand, the company demonstrated exceptional profitability, highlighted by a (3Q earnings surprise) with net profit exceeding expectations by 20%, alongside pricing power through a 10% blanket increase in (maintenance and spare parts). On the other hand, long-term growth catalysts are being reinforced as ASML expands beyond traditional EUV lithography into advanced packaging with its next-generation (hybrid bonding equipment). Despite localized market anxieties regarding European domestic demand, ASML’s technological moat and pricing strategies underpin its strong (market valuation) and secular growth trajectory.

[KR-플랫폼] 10/26 Korea Market Insights

NAVER호재
As a senior equity analyst, the recent strategic partnership between (Naver Cloud) and Vietnam’s largest IT enterprise to drive the (AI Factory business) represents a significant catalyst for NAVER. This initiative marks a crucial milestone in NAVER’s expansion into the broader (Asia-Pacific AI market), diversifying its revenue streams beyond the domestic market and strengthening its global B2B technological competitiveness.
카카오중립
As a senior equity analyst, I evaluate the recent news flow for **Kakao (035720)** as presenting a complex mix of regulatory/execution risks and strategic digital asset initiatives.

The most critical developments center around the (Data Center Investment Delay) highlighted in News [0] and the aggressive push into (Stablecoin Integration) across its core services (Webtoon, Melon, and T) as detailed in News [1] and [4].

1. **Execution Risk:** The potential one-year delay in the 600-billion-won data center project poses a medium-term operational bottleneck, creating uncertainty regarding infrastructure scalability and cost efficiency.
2. **Strategic Innovation:** Conversely, the initiative to issue a (Korean Won-pegged Stablecoin) and link it directly to its commerce, content, and mobility ecosystem represents a bold pivot into Web3 monetization. If successfully integrated with the newly launched (Kakao Membership) and AI services, this could unlock new transaction-fee revenue streams and enhance user lock-in.

While regulatory scrutiny remains a persistent overhang, the strategic leap into blockchain-based settlement warrants close monitoring for long-term valuation impact.

카카오뱅크호재
As a senior equity analyst, I evaluate KakaoBank’s recent strategic moves to expand its addressable market and enhance user engagement. The introduction of the (Foreigner Account Opening Service) targeting the 2.2 million foreign resident population in Korea, alongside partnerships with remittance providers like Hanpass, significantly lowers entry barriers and opens a high-growth untapped market. Furthermore, innovative product launches such as the (AI-powered Target Savings) offering up to 5% interest and daily benefit-customizing check cards are expected to drive customer acquisition and improve (Core Deposit Growth) amid intense digital banking competition.
아프리카TV호재
As a senior equity analyst, I evaluate the recent strategic moves by SOOP (formerly AfreecaTV) as a crucial turning point for valuation multiple expansion. Historically, the company’s revenue model has been overly dependent on its virtual gift system, (Star Balloons). However, recent initiatives to overhaul the user interface, rebrand under the (SOOP) identity, and aggressively scale up (advertising and live commerce) segments indicate a structural diversification of its top-line growth. Furthermore, expanding into high-affinity cultural events like (AGF 2026) strengthens its brand equity among younger demographics and broadens its addressable market beyond traditional streaming. These proactive operational shifts mitigate regulatory risks associated with core donation revenues and enhance long-term earnings visibility.

[KR-반도체] 10/26 Korea Market Insights

삼성전자악재
As a senior equity analyst, the recent market sentiment surrounding Samsung Electronics presents a complex challenge. Despite delivering robust financial performance—often highlighted by massive quarterly operating profits—the company’s stock price continues to experience downward pressure (주가 폭락). This divergence between fundamental earnings and market valuation stems from growing concerns over its competitiveness in the high-bandwidth memory (HBM) sector and macroeconomic uncertainties.

Notably, internal employee sentiments wishing for a lower stock price underscore a severe morale issue, while broader macroeconomic warnings signal that domestic semiconductor leadership is facing structural headwinds. Although executive leadership efforts, such as massive off-market share purchases by Chairman Lee Jae-yong (이재용 장외매수), demonstrate a commitment to shareholder value, restoring investor confidence will require concrete operational turnarounds in advanced memory technologies rather than short-term stabilizing measures.

SK하이닉스중립
As a senior equity analyst, I evaluate the recent news flow for SK Hynix as carrying competing near-term catalysts and risks. On one hand, the company faces potential headwinds including (duplicate listing concerns) regarding Solidigm’s US IPO plans and reported schedule adjustments for (HBM4 back-end equipment). On the other hand, robust market expectations for record-breaking (Q3 operating profit) and potential (additional shareholder returns) continue to underpin fundamental strength, though structural risks like geopolitical overhangs in China warrant close monitoring.
한미반도체호재
As a senior equity analyst, the recent strategic developments for (Hanmi Semiconductor) highlight its dominant position and future growth potential in the AI hardware market.

The company’s showcase of next-generation (HBM4 and advanced packaging equipment) at SEMICON West [0], combined with its strategic expansion beyond HBM into (system semiconductors) [3], demonstrates its technological leadership and broadening addressable market. Furthermore, continuous global orders—such as the recent deal with UTAC Thailand [1]—validate sustained international demand for its back-end semiconductor equipment. These catalysts reinforce its competitive moat in the (AI equipment) sector, supporting a strong, forward-looking valuation.

HPSP호재
As a senior equity analyst, I view the recent news surrounding HPSP as highly encouraging for its long-term growth trajectory. The core catalysts are the company’s strategic expansion beyond its traditional foundry stronghold into the memory semiconductor sector, particularly through the supply of (HPA equipment) across all lines of 300-tier NAND flash. Furthermore, potential diversification of its client base to three major memory makers upon the completion of (DRAM 1d) development reinforces its structural earnings growth potential, driving multiple brokerages to (upgrade target prices).
리노공업악재
As a senior equity analyst, I evaluate the recent developments surrounding Leeno Industrial as mixed in the short term but structurally promising over the long horizon.

The company is currently facing immediate operational headwinds following a prolonged (62-day strike), which has directly impacted its third-quarter earnings, projecting an estimated (20% decline in operating profit). Furthermore, the lingering effects of the production disruption have raised concerns regarding potential (cyclical furloughs/순환휴직) next year due to temporary order lulls.

However, despite these near-term challenges, the investment thesis remains supported by upcoming structural catalysts, notably the (factory relocation in November) which will effectively (double production capacity – CAPA). Combined with the structural rise in demand for (high-value-added test sockets) driven by the accelerated AI era, Leeno Industrial is well-positioned for a robust earnings recovery and high-growth trajectory moving into next year.

[US-SaaS·데이터] 10/24 Wall St. Recap

PLTRSTAY
As a senior equity analyst, Palantir Technologies Inc. (PLTR) presents a complex valuation narrative. While the company demonstrates solid upward momentum supported by strategic security software partnerships, its valuation remains a major point of contention. Trading at an elevated Price-to-Sales (P/S) ratio of 81x, the stock prices in aggressive future growth. However, heightened competition from rivals like Anthropic introduces execution risks that could challenge its market dominance. Wall Street sentiment reflects this dichotomy, with cautious “Neutral” ratings and extreme target price divergences ranging from bullish optimism to severe downside warnings. Consequently, investors should weigh near-term commercial catalysts against stretched valuation multiples.
CRMBULL
As a senior equity analyst, I evaluate the recent strategic developments for Salesforce ((CRM)). The market is focusing on the company’s aggressive moves in AI-driven hyper-personalization, notably highlighted by strategic M&A discussions involving Braze to strengthen its marketing cloud ecosystem. This expansion solidifies (Salesforce)’s competitive moat in enterprise software, driving long-term (revenue growth) and enhancing its (AI monetization) capabilities across global markets.
SNOWBEAR
As a senior equity analyst, I evaluate the recent developments for Snowflake Inc. ((SNOW)). The company’s announcement of a massive (3.5 billion dollar convertible senior notes offering) introduces significant potential (dilution risk) for existing shareholders. While convertible debt provides flexible capital raising, offerings of this scale often create near-term (downward stock pressure) due to hedging activities by institutional investors and concerns over balance sheet leverage. Despite minor daily price fluctuations, the capital structure modification remains the primary driver of investor sentiment.
MDBSTAY
As a senior equity analyst, the recent news landscape for MongoDB ((MDB)) presents a mixed outlook, primarily centered around its upcoming (AI platform launch) and its potential to shift current (bullish sentiment). While technological innovation in AI integration is critical for long-term growth, investors remain watchful of execution risks and broader market valuations. Additionally, minor insider transactions, such as the recent share sale by (CFO Jeremy James), warrant monitoring but do not fundamentally alter the company’s core operational trajectory. Therefore, a balanced, wait-and-see approach is warranted until concrete monetization metrics from the new AI offerings materialize.
NETSTAY
As a senior equity analyst, I have evaluated the recent news regarding **Cloudflare (ticker: NET)**. Among the provided items, news ([1]) is the most relevant, discussing AWS and W컨셉’s large-scale modernization journey utilizing (.NET) technologies. While this highlights the ongoing enterprise adoption and modernization of the (.NET ecosystem), the direct financial and operational impact on Cloudflare is minimal, as Cloudflare operates primarily in the cloud connectivity and security space rather than enterprise software development frameworks. Therefore, this development is categorized as neutral for the company’s near-term equity valuation.

[KR-금융·엔터] 10/24 Korea Market Insights

KB금융악재
As a senior equity analyst, I evaluate the recent news flow surrounding **KB Financial Group (KB금융)** as leaning (negative) due to regulatory uncertainties and internal management pressures. The extension of the Financial Supervisory Service’s (FSS) (regular audit) by two weeks heightened supervisory scrutiny, creating short-term compliance burdens. Simultaneously, discussions surrounding a potential generational shift in leadership create (management uncertainty) as the group navigates complex succession dynamics. While ongoing CSR initiatives reflect strong social responsibility, regulatory and governance-related risks remain the primary drivers impacting near-term sentiment.
메리츠금융지주중립
As a senior equity analyst, I evaluate the recent news flow surrounding (Meritz Financial Group) as a combination of strong fundamental tailwinds and notable regulatory/credit risks. On the positive side, the group continues to demonstrate its commitment to shareholder value, with expectations of maintaining a high (shareholder return rate) of around 50% next year (News [3]), supported by adequate capital buffers from the holding company (News [5]). Conversely, (negative headwinds) persist due to ongoing prosecutorial investigations and (asset soundness concerns) stemming from exposure to troubled project financing and lending, such as the Homeplus-related fallout (News [1], [2]). While robust capital allocation policies and proactive group support underpin its valuation, heightened scrutiny and credit risks warrant close monitoring.
하이브악재
As a senior equity analyst, the most critical news impacting (HYBE) is the correlation between its declining stock price and the financial strain it places on major shareholders like Netmarble ((Stock Price Decline)). The downward pressure on HYBE’s valuation not only dampens market sentiment but also triggers liquidity concerns for institutional investors locked in at higher valuations ((Netmarble)). While minor corporate updates and unrelated content controversies exist, the overarching (Downward Trend) in equity value remains the primary risk factor requiring close monitoring.
JYP Ent악재
As a senior equity analyst, the cancellation of the (75.5 billion KRW new headquarters project) in the Godeok-Gangil district and the decision to sell the land represent a notable shift in JYP Ent.’s capital allocation strategy. While this move alleviates near-term (capex burdens) and potential overinvestment concerns amid a cooling macroeconomic environment, it also signals a setback in the company’s long-term infrastructure and (asset reorganization) plans. Combined with ongoing pressures related to artist lineup maturation and early-tenure growth tasks highlighted by recent brokerage reports, the strategic reversal introduces short-term uncertainty regarding corporate vision and real estate asset efficiency.
에스엠호재
As a senior equity analyst, I evaluate the recent developments surrounding **SM Entertainment** (SM Entertainment) as a turning point for multiple multiple-expansion drivers. The resolution of key (artist contract uncertainties) removes a major overhang that has previously weighed on investor sentiment. Furthermore, major domestic brokerages, including Kiwoom Securities and Daol Investment & Securities, have revised their target prices upward to 120,000 KRW, emphasizing that the market should look past short-term Q3 earnings and focus on clear (growth visibility for next year) driven by robust IP monetization and global expansion.

[US-가상자산·우주] 10/23 Wall St. Recap

MSTRBULL
As a senior equity analyst, I evaluate the recent developments surrounding MicroStrategy (MSTR) as fundamentally positive. The company continues to execute its core treasury strategy by expanding its digital asset reserves, evidenced by the recent acquisition of 1,665 Bitcoin. Despite heightened volatility (94%) compared to the underlying asset, MSTR’s aggressive accumulation model reinforces its unique value proposition as a leveraged equity proxy for Bitcoin, driving recent upward momentum (+5.36%) and strong market interest.
COINSTAY
As a senior equity analyst, I evaluate the current news flow surrounding Coinbase (COIN) as having a mixed impact. While macroeconomic pressures such as rising (Treasury yields) continue to cap (Bitcoin’s upside momentum) and long-term holders are shifting their (liquidation patterns), regulatory headwinds also persist, evidenced by the €3.25 million fine imposed on (Coinbase Ireland) for client asset protection breaches. However, these factors represent ongoing macroeconomic and compliance friction rather than a structural deterioration of the core investment thesis. Therefore, the overall sentiment remains neutral as the market digests these developments.
MARASTAY
As a senior equity analyst, the recent developments surrounding (MARA Holdings) present a dual narrative. While the (CFO’s insider selling) of $126,080 worth of shares (News [2]) may trigger short-term retail caution, the more structurally significant development is the company’s (strategic pivot toward AI) coupled with a substantial (Bitcoin transfer) of $81.1 million to Galaxy Digital (News [4]). This move underscores MARA’s aggressive diversification into high-performance computing and (AI infrastructure), which could redefine its valuation multiples beyond traditional crypto-mining volatility. Investors should closely monitor how this (capital reallocation) impacts future operational efficiency and revenue streams.
LMTBULL
As a senior equity analyst, the recent news surrounding Lockheed Martin (LMT) underscores a robust fundamental outlook driven by strong financial performance and surging global demand.

Key drivers for the recent 3.65% to over 5% stock rally include the company’s Q3 financial results, which surpassed consensus expectations with an 11% year-over-year increase in revenue to (207 billion dollars). More importantly, LMT reported an all-time high (order backlog) of (292 billion dollars), significantly bolstered by recent (missile production facility expansions).

This record backlog provides exceptional revenue visibility amidst heightened geopolitical tensions. Combined with potential (undervaluation) signals relative to its growth trajectory, LMT remains a strong defensive play with solid medium-term upside potential.

RKLBBULL
As a senior equity analyst, I evaluate the recent developments surrounding Rocket Lab (RKLB). The recent (multi-launch contract) with Japan’s Synspective for 20 Electron rocket missions (News [0]) and the growing (backlog exceeding 100 launches) with a bullish 2026 average price target of $109 (News [1]) underscore the company’s dominant market position in small-lift launch services and robust long-term revenue visibility. While short-term headwinds such as the (Neutron rocket launch delay) (News [4]) and valuation pressures (News [3]) have caused volatility, the core operational momentum and expanding commercial pipeline validate a constructive structural outlook.

[KR-방산·우주] 10/23 Korea Market Insights

한화에어로스페이스호재
As a senior equity analyst, I evaluate the recent news flow for (Hanwha Aerospace) as net positive for its long-term valuation, driven by major technological milestones despite minor operational headwinds.

Among the news items, (News [1]) regarding the development of the 10,000-lbf class domestic aircraft engine and (News [3]) regarding the manufacturing contract for Korea’s first lunar orbit transport vehicle are of paramount importance. These developments solidify the company’s status as a national champion in both (aerospace propulsion) and (space exploration). While safety and labor-related issues ((News [4])) require immediate risk management to prevent regulatory blowback, the technological and strategic expansion into high-value defense and aerospace sectors outweighs near-term noise, providing a strong structural growth catalyst.

현대로템호재
As a senior equity analyst, I evaluate the recent strategic moves by Hyundai Rotem. The acquisition of Hyundai Wia’s defense business for approximately 358.4 billion KRW represents a pivotal milestone in achieving complete (vertical integration) within the defense sector. Despite short-term concerns regarding export margins highlighted in market reports, this consolidation will significantly enhance manufacturing efficiency, secure core component supply chains, and strengthen long-term (competitiveness in global defense markets). Furthermore, showcasing next-generation technologies at international rail exhibitions underscores the robust growth potential of its (railway segment) alongside defense.
LIG넥스원악재
As a senior equity analyst, the recent regulatory action by the Defense Acquisition Program Administration (DAPA) imposing a 2-year (bidding restriction) on LIG D&A introduces substantial (regulatory risk) and (earnings uncertainty) for LIG넥스원. While the company maintains robust overseas momentum—evidenced by potential demand for its ‘Haeseong’ missile systems in Malaysia and ongoing ‘Cheongung’ (M-SAM) export demand—domestic procurement setbacks and potential (production bottlenecks) weigh heavily on near-term valuation multiples and domestic order inflow visibility.
한국항공우주악재
As a senior equity analyst, the recent news surrounding potential (Privatization) discussions involving the Export-Import Bank of Korea (KEXIM), the largest shareholder of (Korea Aerospace Industries – KAI), introduces significant corporate governance uncertainties. The controversy highlighted during the (National Audit) regarding controversial consulting services and subsequent (Labor Union Protests) near the presidential office creates near-term operational friction and sentiment headwinds for the stock.
풍산악재
As a senior equity analyst, the recent news flow surrounding Poongsan reflects a short-term operational mismatch and earnings adjustment. While the structural demand for the company’s defense segment—particularly (155mm artillery shells)—remains robust globally, recent reports highlight a (surge in inventories) amounting to approximately 840. billion KRW in defense stockpiles. This inventory accumulation, coupled with projected third-quarter earnings falling below consensus expectations, has prompted target price downgrades from major brokerages like KB Securities. Consequently, near-term sentiment is weighed down by earnings (misses) and working capital efficiency concerns, despite long-term catalysts such as the Centum 2 district relocation progress.

[US-헬스케어] 10/22 Wall St. Recap

LLYBULL
As a senior equity analyst, I evaluate the recent market performance of Eli Lilly and Co. (LLY). Despite broader market volatility and a slight decline in the S&P 500, LLY demonstrated relative strength with a 3.70% upward movement driven by positive sentiment. Furthermore, major financial institutions like RBC Capital have upgraded the healthcare sector to overweight, highlighting LLY as a core stock alongside robust earnings outlook revisions. This underscores strong institutional confidence and sustained growth momentum in its pharmaceutical portfolio.
NVOBEAR
As a senior equity analyst, I evaluate the recent developments surrounding Novo Nordisk A/S (NVO) as a mix of near-term headwinds and intensifying competitive pressures. The company has experienced notable stock volatility, driven by concerns over (declining U.S. market share) and subsequent (target price downgrades) from major financial institutions like BMO regarding key blockbuster drugs such as Ozempic. Furthermore, while the unveiling of long-term pipeline targets is strategically crucial for future growth, it initially triggered stock slides due to heightened execution risks and market expectations. Compounding these challenges, broader retail health initiatives—such as Walmart’s new employee prescription drug coverage including major weight-loss and diabetes treatments—signal a shifting pricing and distribution landscape that may squeeze (profit margins). Consequently, these factors point to a cautious near-term outlook for NVO.
AMGNBULL
As a senior equity analyst, I evaluate the recent positive development for Amgen Inc. (AMGN). The announcement of (Positive Phase 3 Sjögren’s Disease Trial Results) serves as a major catalyst, driving investor confidence and lifting the stock by 3.06% in recent trading sessions. This clinical success strengthens Amgen’s late-stage (Pipeline Portfolio), diversifying its revenue streams beyond established core products and reinforcing its long-term (Growth Outlook) in specialty therapeutics.
UNHBULL
As a senior equity analyst, the recent upward movement of UnitedHealth Group (NYSE: UNH)—highlighted by a 3.77% gain—is primarily driven by a strong (earnings surprise) and a subsequent upward revision in its (annual guidance), extending positive momentum toward future performance outlooks like 2026. This fundamental strength reinforces institutional confidence and underscores the company’s robust operational resilience within the managed healthcare sector, overshadowing near-term valuation debates.
PFEBULL
As a senior equity analyst, I evaluate the recent market developments for Pfizer Inc. (PFE). The stock recently demonstrated a positive price movement, gaining 3.14% on October 14, driven by renewed investor optimism and underlying fundamental catalysts. Furthermore, strategic industry developments highlight the company’s expanding influence and robust supply chain positioning, particularly regarding its engagement with major global battery and pharmaceutical supply networks. These factors collectively reinforce PFE‘s near-term market momentum and strengthen institutional confidence.

[KR-바이오] 10/22 Korea Market Insights

삼성바이오로직스호재
As a senior equity analyst, I evaluate Samsung Biologics’ recent performance and strategic outlook as strongly favorable. The company reported a record-breaking (3Q performance) with revenue of 1.49 trillion KRW and an operating profit of 640.1 billion KRW, driven by robust momentum in its core (CDMO business). Furthermore, favorable market conditions and proactive global networking position the company well for aggressive capacity expansion and potential (M&A opportunities), solidifying its dominant position in the global biopharmaceutical market.
셀트리온호재
As a senior equity analyst, I evaluate the recent developments for (Celltrion) as fundamentally favorable for its mid-to-long-term growth trajectory.

The primary driver is the strategic entry of (Omlyclo) into the United States market. Launching into a segment with limited immediate (biosimilar) competition positions the company to capture early market share and expand its high-margin product portfolio. Additionally, ongoing infrastructure expansion, such as the (Osong plant) investment by Chairman Seo Jung-jin, reinforces operational readiness to meet rising global demand. While the stock has experienced consolidation year-to-date, these operational catalysts and new product rollouts are expected to drive a (valuation rebound).

유한양행중립
As Yuhan Corporation approaches a leadership transition amid speculation over its next CEO (차기 사장), the company faces a critical juncture beyond management changes. While market expectations rise regarding its Active Pharmaceutical Ingredient (API) and Contract Development and Manufacturing Organization (CDMO) business expansion showcased at CPHI Milan, the ultimate investment thesis relies on securing a robust pipeline strategy (포스트 렉라자) to sustain its growth momentum following the blockbuster success of Leclaza.
알테오젠호재
As a senior equity analyst, I evaluate (Alteogen)‘s recent developments as highly constructive for its mid-to-long-term valuation. The successful securing of the (Keytruda SC European composition patent) significantly diminishes intellectual property risks and clears the path for global commercialization. Furthermore, securing (200 billion won in capital) through the People’s Growth Fund, alongside the absorption merger of Alteogen Biologics, strengthens financial flexibility and streamlines operational efficiencies for future (technology exports) and pipeline expansion.
HLB중립
As a senior equity analyst, the recent news flow surrounding HLB centers on the company’s persistent efforts to secure U.S. FDA approval for its liver cancer drug (rivoceranox/rivoceranib combination). Following previous regulatory hurdles, HLB has officially submitted a (re-application) to the FDA, while management—including Chairman Jin Yang-gon—has outlined aggressive growth strategies, including potential (Big Pharma partnerships). While the re-submission is a critical step toward commercialization, the market remains cautious given the historical (regulatory setbacks) and valuation risks. Therefore, a neutral stance is warranted until tangible progress or official FDA feedback is confirmed.

[US-전기차·에너지] 10/21 Wall St. Recap

TSLABULL
As a senior equity analyst, I evaluate Tesla’s recent developments as a mix of aggressive growth funding and strategic market expansion. The acquisition of a massive (30 billion USD, approx. 42 trillion KRW credit line) provides crucial liquidity to accelerate the production of next-generation growth drivers such as the (Cybercab and Optimus). Furthermore, Tesla’s official entry into (Vietnam), the fastest-growing EV market in Southeast Asia, underscores its long-term regional expansion strategy despite short-term valuation debates.
RIVNSTAY
As a senior equity analyst, I evaluate (RIVN) through a mixed lens of near-term valuation concerns and long-term structural catalysts. While the stock has experienced a significant correction—down 33% year-to-date—raising valid questions about (overvaluation) amid challenging market conditions ([0]), the company continues to demonstrate operational resilience. Specifically, maintaining its annual guidance with steady Q3 production and deliveries ([4]), alongside a high-margin (software gross profit) of $215 million ([3]), underscores its evolving business model. Ultimately, future stock performance will heavily depend on successful execution of the (R2 platform ramp-up) and autonomous driving roadmaps ([1]).
XOMBEAR
As a senior equity analyst, I note that ExxonMobil (XOM) is facing (legal and financial risks) following its rejection of a $5 billion settlement offer related to the Kashagan dispute. While the company benefits from tailwinds such as strong (refining margins) and potential undervaluation, the unresolved arbitration and regulatory disputes introduce unnecessary (downside volatility) that could overshadow near-term operational gains.
FSLRBULL
As a senior equity analyst, I evaluate the recent developments surrounding First Solar (FSLR). Despite a recent pullback (such as the 7.12% decline noted in News [0]), major financial institutions have turned increasingly constructive on the stock. Notably, Goldman Sachs highlighted a significant (51% Upside) potential after the stock corrected roughly 43% from its June highs (News [3]). Furthermore, KeyBanc upgraded its rating, pointing to a much-needed (Valuation Relief) (News [2]), while Truist raised its price target, bolstered by favorable (Import Regulations) providing a competitive moat against foreign influx (News [4]). These factors suggest that the recent dip offers an attractive entry point for long-term investors looking past short-term policy or tax credit expiration noise.
VSTBULL
As a senior equity analyst, I evaluate the recent developments surrounding Vistra Corp (VST). The execution of a (20-year long-term power supply agreement) with New Era Energy marks a monumental catalyst, cementing VST’s position as a premier energy supplier catering to high-demand sectors like AI and data centers. Furthermore, significant stock momentum—including a notable (11.79% surge)—reflects robust institutional confidence and underlying fundamental strength, despite capital structure adjustments such as preferred stock redemption. This long-term contract guarantees stable, recurring cash flows, enhancing VST’s long-term valuation appeal.